Skip to main content
. 2021 Oct 26;13(21):5362. doi: 10.3390/cancers13215362

Figure 4.

Figure 4

Kaplan–Meier survival curves for oligodendroglioma based on TP53 mutation status. (A) Overall survival and (B) progression-free survival stratified by TP53 wild-type and TP53 mutant cases in our dataset. (C) Overall survival and (D) progression-free survival curves for the TCGA oligodendroglioma dataset, stratified by TP53 wild-type and TP53 mutant cases. (E) Overall survival and (F) progression-free survival curves for the TCGA oligodendroglioma dataset, stratified by TP53 wild-type, TP53 codon 273 mutant, and other TP53 mutant cases. TP53 273: TP53 codon 273 mutant, TP53 OTHER: all pathogenic TP53 mutations except in codon 273, TP53 WT: wild-type TP53 status. Log-rank test was used for analysis and a p-value < 0.05 for statistical significance.